Background Variations in the age patterns and magnitudes of excess deaths, as well as differences in population sizes and age structures, make cross-national comparisons of the cumulative mortality impacts of the COVID-19 pandemic challenging. Life expectancy is a widely used indicator that provides a clear and cross-nationally comparable picture of the population-level impacts of the pandemic on mortality. Methods Life tables by sex were calculated for 29 countries, including most European countries, Chile and the USA, for 2015–2020. Life expectancy at birth and at age 60 years for 2020 were contextualized against recent trends between 2015 and 2019. Using decomposition techniques, we examined which specific age groups contributed to reductions in life expectancy in 2020 and to what extent reductions were attributable to official COVID-19 deaths. Results Life expectancy at birth declined from 2019 to 2020 in 27 out of 29 countries. Males in the USA and Lithuania experienced the largest losses in life expectancy at birth during 2020 (2.2 and 1.7 years, respectively), but reductions of more than an entire year were documented in 11 countries for males and 8 among females. Reductions were mostly attributable to increased mortality above age 60 years and to official COVID-19 deaths. Conclusions The COVID-19 pandemic triggered significant mortality increases in 2020 of a magnitude not witnessed since World War II in Western Europe or the breakup of the Soviet Union in Eastern Europe. Females from 15 countries and males from 10 ended up with lower life expectancy at birth in 2020 than in 2015.

The human lifespan has traversed a long evolutionary and historical path, from short-lived primate ancestors to contemporary Japan, Sweden, and other longevity frontrunners. Analyzing this trajectory is crucial for understanding biological and sociocultural processes that determine the span of life. Here we reveal a fundamental regularity. Two straight lines describe the joint rise of life expectancy and lifespan equality: one for primates and the second one over the full range of human experience from average lifespans as low as 2 y during mortality crises to more than 87 y for Japanese women today. Across the primate order and across human populations, the lives of females tend to be longer and less variable than the lives of males, suggesting deep evolutionary roots to the male disadvantage. Our findings cast fresh light on primate evolution and human history, opening directions for research on inequality, sociality, and aging.biodemography | equality | lifespan | pace and shape | senescence L ongevous populations have two characteristics: The average length of life is long and relative variation in lifespans is low. For example, life tables for contemporary Sweden and Japan indicate that most deaths occur at ages between the late 70s and early 90s. Our primate relatives, in contrast, have lifespans that are highly variable in length but short on average and rarely longer than 30 y (Fig. 1). An association between the average length of life and its variability has been found for industrialized societies (1, 2). However, detailed knowledge is lacking about whether and how this association varies across species separated by millions of years of primate evolution or whether it has changed over the past several centuries of unprecedented social progress in human populations. Fuller comprehension of the relationship between rising lifespans and reduced lifespan variability across evolution and history holds potential insights that might illuminate past, current, and future longevity.We pose three related questions aimed at filling this knowledge gap: How long and variable are lifespans for humans compared with nonhuman primates, for humans today compared with the past, and for males compared with females? We provide answers to these questions by applying a powerful framework that simultaneously examines changes in both the average length of life in a population or species-the "pace" of life-and relative variation in the length of life, i.e., the "shape" of the distribution of ages at death (3-5). Studying variation in lifespan links to increasing interest in social, economic, and health inequalities and to key sociological findings that relate social factors-including high social status and social integration-to longer, healthier lifespans in human and animal societies (6-10).Estimating the average length of life (here measured by life expectancy, the mean age at death) and variation in lifespans relative to the average (measured here as "lifespan equality"; Box 1) requires data on the ages at death of individuals...

BackgroundDeaths directly linked to COVID-19 infection may be misclassified, and the pandemic may have indirectly affected other causes of death. To overcome these measurement challenges, we estimate the impact of the COVID-19 pandemic on mortality, life expectancy and lifespan inequality from week 10 of 2020, when the first COVID-19 death was registered, to week 47 ending 20 November 2020 in England and Wales through an analysis of excess mortality.MethodsWe estimated age and sex-specific excess mortality risk and deaths above a baseline adjusted for seasonality with a systematic comparison of four different models using data from the Office for National Statistics. We additionally provide estimates of life expectancy at birth and lifespan inequality defined as the SD in age at death.ResultsThere have been 57 419 (95% prediction interval: 54 197, 60 752) excess deaths in the first 47 weeks of 2020, 55% of which occurred in men. Excess deaths increased sharply with age and men experienced elevated risks of death in all age groups. Life expectancy at birth dropped 0.9 and 1.2 years for women and men relative to the 2019 levels, respectively. Lifespan inequality also fell over the same period by 5 months for both sexes.ConclusionQuantifying excess deaths and their impact on life expectancy at birth provide a more comprehensive picture of the burden of COVID-19 on mortality. Whether mortality will return to—or even fall below—the baseline level remains to be seen as the pandemic continues to unfold and diverse interventions are put in place.